Browse by author
Lookup NU author(s): Professor Derek Mann
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The last decade has seen a rapid expansion in our understanding of the mechanisms leading to hepatic stellate cell activation. The classic activation pathway of initiation, perpetuation and regression remains as a useful model; however, the emergence of several new pathways and mediators has revealed a deeper complexity than previously appreciated. Although core fibrogenic pathways exist across organs and disease types, there is accumulating evidence for disease-and context-specific mechanisms that may modulate or drive hepatic fibrogenesis. Hence, a "one size fits all" approach to antifibrotic therapy may not be appropriate for all disease settings. The authors present a focused and concise update of the most recent advances in our understanding of hepatic stellate cell activation pathways, while highlighting several challenges that may be constraining progress. This summary provides a foundation to further expand our knowledge of this unique cell type and its contributions to human liver disease.
Author(s): Wallace MC, Friedman SL, Mann DA
Publication type: Review
Publication status: Published
Journal: Seminars in Liver Disease
Year: 2015
Volume: 35
Issue: 2
Pages: 107-118
Print publication date: 01/05/2015
Acceptance date: 01/01/1900
ISSN (print): 0272-8087
ISSN (electronic): 1098-8971
Publisher: THIEME MEDICAL PUBL INC
URL: http://dx.doi.org/10.1055/s-0035-1550060
DOI: 10.1055/s-0035-1550060
